文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

比较 mRNA-1273 和 BNT162b2 疫苗在德尔塔变异株为主流行期间对突破性 SARS-CoV-2 感染、住院和死亡的效果。

Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period.

机构信息

Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Center for Community Health Integration, Case Western Reserve University School of Medicine, Cleveland, Ohio.

出版信息

JAMA. 2022 Feb 15;327(7):678-680. doi: 10.1001/jama.2022.0210.

DOI:10.1001/jama.2022.0210
PMID:35050314
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8778597/
Abstract

This study examines breakthrough SARS-CoV-2 infections, hospitalizations, and mortality in March-August 2021, when the Delta variant predominated, among a general US cohort vaccinated with mRNA-1273 or BNT162b2.

摘要

本研究考察了 2021 年 3 月至 8 月期间，德尔塔变异株占主导地位时，在美国普通人群中使用 mRNA-1273 或 BNT162b2 疫苗接种者中突破性 SARS-CoV-2 感染、住院和死亡情况。

相似文献

[1]
Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period.

JAMA. 2022-2-15

[2]
Effectiveness of mRNA booster doses in preventing infections and hospitalizations due to SARS-CoV-2 and its dominant variant over time in Valencian healthcare workers, Spain.

Vaccine. 2024-7-25

[3]
Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.

JAMA. 2022-10-11

[4]
Covid-19 Vaccine Effectiveness in New York State.

N Engl J Med. 2022-1-13

[5]
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.

JAMA. 2021-11-23

[6]
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.

Lancet. 2022-2-12

[7]
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.

JAMA. 2022-2-15

[8]
Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina.

N Engl J Med. 2022-3-10

[9]
Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Patients on Hemodialysis.

J Am Soc Nephrol. 2022-1

[10]
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021.

Science. 2022-1-21

引用本文的文献

[1]
GLP-1 RA Use and Major Adverse Cardiovascular Events in Patients With Monoclonal Gammopathy of Undetermined Significance.

JAMA Netw Open. 2025-6-2

[2]
Patients With Inflammatory Bowel Disease Are at Increased Risk of Respiratory Syncytial Virus Infections After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Propensity-Matched Cohort Analysis.

Clin Transl Gastroenterol. 2025-5-1

[3]
Longitudinal Surveillance of COVID-19 Antibodies in Pediatric Healthcare Workers.

Vaccines (Basel). 2025-2-7

[4]
Artificial intelligence-based drug repurposing with electronic health record clinical corroboration: A case for ketamine as a potential treatment for amphetamine-type stimulant use disorder.

Addiction. 2025-4

[5]
Association between selective serotonin reuptake inhibitors and mortality following COVID-19 among patients with Alzheimer's disease.

J Alzheimers Dis. 2024-11

[6]
Risk of Suicidal Ideation or Attempts in Adolescents With Obesity Treated With GLP1 Receptor Agonists.

JAMA Pediatr. 2024-12-1

[7]
Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters.

Sci Adv. 2024-8-2

[8]
Association of adverse cardiovascular events with gabapentin and pregabalin among patients with fibromyalgia.

PLoS One. 2024

[9]
Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes.

JAMA Netw Open. 2024-7-1

[10]
Real-World Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 on Inpatient and Medically Attended COVID-19 Among Immunocompromised US Adults.

Infect Dis Ther. 2024-8

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索